P2RX7 and neurodegenerative disease: In an AD model study, it was showed that inhibition of P2X7 receptor with antagonists could reduce the level of amyloid plaque and hinder the progression of the disease, indicating P2X7 receptor as a potential therapeutic target for neurodegenerative diseases (Rodrigues et al., 2015).